(S (NP (NP (JJ Prognostic) (NN information)) (PP (IN at) (NP (NN diagnosis)))) (VP (VBZ has) (NP (NP (JJ important) (NNS implications)) (PP (IN for) (NP (NN cancer) (NN treatment) (CC and) (NN monitoring))))) (. .))
(S (SBAR (IN Although) (S (NP (NP (NN cancer) (NN staging)) (, ,) (NP (JJ histopathological) (NN assessment)) (, ,) (NP (JJ molecular) (NNS features)) (, ,) (CC and) (NP (JJ clinical) (NNS variables))) (VP (MD can) (VP (VB provide) (NP (JJ useful) (JJ prognostic) (NNS insights)))))) (, ,) (S (VP (VBG improving) (NP (NN risk) (NN stratification)))) (VP (VBZ remains) (NP (DT an) (JJ active) (NN research) (NN area))) (. .))
(S (NP (PRP We)) (VP (VBD developed) (NP (NP (DT a) (JJ deep) (NN learning) (NN system)) (PRN (-LRB- -LRB-) (NP (NNP DLS)) (-RRB- -RRB-)) (SBAR (S (VP (TO to) (VP (VB predict) (NP (ADJP (NN disease) (JJ specific)) (NN survival)) (PP (IN across) (NP (CD 10) (NN cancer) (NNS types))) (PP (IN from) (NP (NP (DT The) (NNP Cancer) (NNP Genome) (NNP Atlas)) (PRN (-LRB- -LRB-) (NP (NNP TCGA)) (-RRB- -RRB-)))))))))) (. .))
(S (NP (PRP We)) (VP (VP (VBD used) (NP (NP (DT a) (JJ weakly-supervised) (NN approach)) (PP (IN without) (NP (JJ pixel-level) (NNS annotations))))) (, ,) (CC and) (VP (VBD tested) (NP (CD three) (JJ different) (JJ survival) (NN loss) (NNS functions)))) (. .))
(S (NP (DT The) (NNP DLS)) (VP (VBD was) (VP (VP (VBN developed) (S (VP (VBG using) (NP (NP (CD 9,086) (NNS slides)) (PP (IN from) (NP (CD 3,664) (NNS cases))))))) (CC and) (VP (VBD evaluated) (S (VP (VBG using) (NP (NP (CD 3,009) (NNS slides)) (PP (IN from) (NP (CD 1,216) (NNS cases))))))))) (. .))
(S (PP (IN In) (NP (NP (JJ multivariable) (NNP Cox) (NN regression) (NN analysis)) (PP (IN of) (NP (NP (DT the) (JJ combined) (NN cohort)) (PP (VBG including) (NP (DT all) (CD 10) (NNS cancers))))))) (, ,) (NP (DT the) (NNP DLS)) (VP (VBD was) (VP (ADVP (RB significantly)) (VBN associated) (PP (IN with) (NP (NP (ADJP (NN disease) (JJ specific)) (NN survival)) (PRN (-LRB- -LRB-) (NP (NP (JJ hazard) (NN ratio)) (PP (IN of) (NP (NP (CD 1.58)) (, ,) (NP (CD 95) (NN %) (NNP CI) (NP (CD 1.28-1.70))))) (, ,) (NP (VBZ p) (NNP <) (CD 0.0001))) (-RRB- -RRB-)))) (PP (IN after) (S (VP (VBG adjusting) (PP (IN for) (NP (NP (NN cancer) (NN type)) (, ,) (NP (NN stage)) (, ,) (NP (NN age)) (, ,) (CC and) (NP (NN sex))))))))) (. .))
(S (PP (IN In) (NP (DT a) (NN per-cancer) (VBN adjusted) (NN subanalysis))) (, ,) (NP (DT the) (NNP DLS)) (VP (VBD remained) (NP (NP (DT a) (JJ significant) (NN predictor)) (PP (IN of) (NP (NN survival)))) (PP (IN in) (NP (QP (CD 5) (IN of) (CD 10)) (NN cancer) (NNS types)))) (. .))
(S (PP (VBN Compared) (PP (TO to) (NP (NP (DT a) (NN baseline) (NN model)) (PP (VBG including) (NP (NN stage) (, ,) (NN age) (, ,) (CC and) (NN sex)))))) (, ,) (NP (NP (DT the) (NN c-index)) (PP (IN of) (NP (DT the) (NN model)))) (VP (VBD demonstrated) (NP (NP (DT an) (JJ absolute) (ADJP (CD 3.7) (NN %)) (NN improvement)) (PRN (-LRB- -LRB-) (NP (ADJP (CD 95) (NN %)) (NNP CI) (CD 1.0-6.5)) (-RRB- -RRB-))) (PP (IN in) (NP (DT the) (JJ combined) (NN cohort)))) (. .))
(S (ADVP (RB Additionally)) (, ,) (NP (PRP$ our) (NNS models)) (VP (VBN stratified) (NP (NNS patients)) (PP (IN within) (NP (NP (JJ individual) (NN cancer) (NNS stages)) (, ,) (ADVP (RB particularly)) (NP (NP (NP (NN stage) (NNP II)) (PRN (-LRB- -LRB-) (NP (NN p=0.025)) (-RRB- -RRB-))) (CC and) (NP (NP (NN stage) (NNP III)) (PRN (-LRB- -LRB-) (NP (JJ p) (NNP <) (CD 0.001)) (-RRB- -RRB-))))))) (. .))
(S (PP (IN By) (S (VP (VBG developing) (CC and) (VBG evaluating) (NP (JJ prognostic) (NNS models)) (PP (IN across) (NP (JJ multiple) (NN cancer) (NNS types)))))) (, ,) (NP (DT this) (NN work)) (VP (VBZ represents) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (ADJP (RBS most) (JJ comprehensive)) (NNS studies)) (VP (VBG exploring) (NP (NP (DT the) (JJ direct) (NN prediction)) (PP (IN of) (NP (JJ clinical) (NNS outcomes)))) (S (VP (VBG using) (NP (NP (JJ deep) (NN learning)) (CC and) (NP (NN histopathology) (NNS images)))))))))) (. .))
(S (NP (PRP$ Our) (NN analysis)) (VP (VBZ demonstrates) (NP (DT the) (NN potential) (SBAR (IN for) (S (NP (DT this) (NN approach)) (VP (TO to) (VP (VB provide) (NP (JJ prognostic) (NN information)) (PP (PP (IN in) (NP (JJ multiple) (NN cancer) (NNS types))) (, ,) (CC and) (ADVP (RB even)) (PP (IN within) (NP (JJ specific) (JJ pathologic) (NNS stages)))))))))) (. .))
(S (ADVP (RB However)) (, ,) (PP (VBN given) (NP (NP (DT the) (ADJP (RB relatively) (JJ small)) (NN number)) (PP (IN of) (NP (JJ clinical) (NNS events))))) (, ,) (NP (PRP we)) (VP (VBD observed) (NP (JJ wide) (NN confidence) (NNS intervals)) (, ,) (S (VP (VBG suggesting) (SBAR (IN that) (S (NP (JJ future) (NN work)) (VP (MD will) (VP (VB benefit) (PP (IN from) (NP (JJR larger) (NNS datasets)))))))))) (. .))
